Bicara Therapeutics Expands Clinical Team with Appointments of Jeltje Schulten, M.D., MBA, as SVP of Clinical and Medical Affairs and Rita Dalal, MBBS, MPH, as VP of Clinical Development
Bicara Therapeutics Expands Clinical Team with Appointments of Jeltje Schulten, M.D., MBA, as SVP of Clinical and Medical Affairs and Rita Dalal, MBBS, MPH, as VP of Clinical Development
RSM MBA alumna Jeltje Schulten, MD, MBA,has been appointed as SVP of clinical and medical affairs by Bicara Therapeutics, a clinical-stage biotechnology company developing dual-action biologics to elicit a potent and durable immune response,
RSM uses cookies to measure website statistics, enable social media sharing and for marketing purposes.
By clicking accept cookies or by continuing to use this website, you are giving consent for us to set cookies when visiting this website.
See our cookie policy for more information about cookies and how to adjust your cookie settings.